Joe Neighbour has been tracking GlaxoSmithKline, a big pharma stock that seems to be in a...

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

This week the New York Times, in an editorial, urged US lawmakers to legalise marijuana. Some...

AstraZeneca’s stock price tumbled 14 percent on Monday morning after the company rejected...

As the Astra Zeneca Pfizer deal gets more bad tempered and political, what are the side effects...

Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects...

The US healthcare sector is booming due to a combination of Obamacare and the approval of new...